Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features

ObjectivesA subset of non-functioning pituitary macroadenomas (NFMAs) may exhibit early progression/recurrence (P/R) after tumor resection. The purpose of this study was to apply deep learning (DL) algorithms for prediction of P/R in NFMAs.MethodsFrom June 2009 to December 2019, 78 patients diagnose...

Full description

Bibliographic Details
Main Authors: Yan-Jen Chen, Hsun-Ping Hsieh, Kuo-Chuan Hung, Yun-Ju Shih, Sher-Wei Lim, Yu-Ting Kuo, Jeon-Hor Chen, Ching-Chung Ko
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.813806/full
_version_ 1818028573605232640
author Yan-Jen Chen
Yan-Jen Chen
Hsun-Ping Hsieh
Kuo-Chuan Hung
Kuo-Chuan Hung
Yun-Ju Shih
Sher-Wei Lim
Sher-Wei Lim
Yu-Ting Kuo
Yu-Ting Kuo
Jeon-Hor Chen
Jeon-Hor Chen
Ching-Chung Ko
Ching-Chung Ko
Ching-Chung Ko
author_facet Yan-Jen Chen
Yan-Jen Chen
Hsun-Ping Hsieh
Kuo-Chuan Hung
Kuo-Chuan Hung
Yun-Ju Shih
Sher-Wei Lim
Sher-Wei Lim
Yu-Ting Kuo
Yu-Ting Kuo
Jeon-Hor Chen
Jeon-Hor Chen
Ching-Chung Ko
Ching-Chung Ko
Ching-Chung Ko
author_sort Yan-Jen Chen
collection DOAJ
description ObjectivesA subset of non-functioning pituitary macroadenomas (NFMAs) may exhibit early progression/recurrence (P/R) after tumor resection. The purpose of this study was to apply deep learning (DL) algorithms for prediction of P/R in NFMAs.MethodsFrom June 2009 to December 2019, 78 patients diagnosed with pathologically confirmed NFMAs, and who had undergone complete preoperative MRI and postoperative MRI follow-up for more than one year, were included. DL classifiers including multi-layer perceptron (MLP) and convolutional neural network (CNN) were used to build predictive models. Categorical and continuous clinical data were fed into the MLP model, and images of preoperative MRI (T2WI and contrast enhanced T1WI) were analyzed by the CNN model. MLP, CNN and multimodal CNN-MLP architectures were performed to predict P/R in NFMAs.ResultsForty-two (42/78, 53.8%) patients exhibited P/R after surgery. The median follow-up time was 42 months, and the median time to P/R was 25 months. As compared with CNN using MRI (accuracy 83%, precision 87%, and AUC 0.84) or MLP using clinical data (accuracy 73%, precision 73%, and AUC 0.73) alone, the multimodal CNN-MLP model using both clinical and MRI features showed the best performance for prediction of P/R in NFMAs, with accuracy 83%, precision 90%, and AUC 0.85.ConclusionsDL architecture incorporating clinical and MRI features performs well to predict P/R in NFMAs. Pending more studies to support the findings, the results of this study may provide valuable information for NFMAs treatment planning.
first_indexed 2024-12-10T05:05:57Z
format Article
id doaj.art-382d270eaaea4d5392e1d203c144830e
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-10T05:05:57Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-382d270eaaea4d5392e1d203c144830e2022-12-22T02:01:14ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-04-011210.3389/fonc.2022.813806813806Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI FeaturesYan-Jen Chen0Yan-Jen Chen1Hsun-Ping Hsieh2Kuo-Chuan Hung3Kuo-Chuan Hung4Yun-Ju Shih5Sher-Wei Lim6Sher-Wei Lim7Yu-Ting Kuo8Yu-Ting Kuo9Jeon-Hor Chen10Jeon-Hor Chen11Ching-Chung Ko12Ching-Chung Ko13Ching-Chung Ko14Department of Electrical Engineering, National Cheng Kung University, Tainan, TaiwanGraduate Institute of Electronics Engineering, National Taiwan University, Taipei, TaiwanDepartment of Electrical Engineering, National Cheng Kung University, Tainan, TaiwanDepartment of Anesthesiology, Chi Mei Medical Center, Tainan, TaiwanDepartment of Hospital and Health Care Administration, College of Recreation and Health Management, Chia Nan University of Pharmacy and Science, Tainan, TaiwanDepartment of Medical Imaging, Chi-Mei Medical Center, Tainan, TaiwanDepartment of Neurosurgery, Chi Mei Medical Center, Tainan, TaiwanDepartment of Nursing, Min-Hwei College of Health Care Management, Tainan, TaiwanDepartment of Medical Imaging, Chi-Mei Medical Center, Tainan, TaiwanDepartment of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanDepartment of Radiological Sciences, University of California, Irvine, Irvine, CA, United States0Department of Radiology, E-DA Hospital, I-Shou University, Kaohsiung, TaiwanDepartment of Medical Imaging, Chi-Mei Medical Center, Tainan, Taiwan1Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan2Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, TaiwanObjectivesA subset of non-functioning pituitary macroadenomas (NFMAs) may exhibit early progression/recurrence (P/R) after tumor resection. The purpose of this study was to apply deep learning (DL) algorithms for prediction of P/R in NFMAs.MethodsFrom June 2009 to December 2019, 78 patients diagnosed with pathologically confirmed NFMAs, and who had undergone complete preoperative MRI and postoperative MRI follow-up for more than one year, were included. DL classifiers including multi-layer perceptron (MLP) and convolutional neural network (CNN) were used to build predictive models. Categorical and continuous clinical data were fed into the MLP model, and images of preoperative MRI (T2WI and contrast enhanced T1WI) were analyzed by the CNN model. MLP, CNN and multimodal CNN-MLP architectures were performed to predict P/R in NFMAs.ResultsForty-two (42/78, 53.8%) patients exhibited P/R after surgery. The median follow-up time was 42 months, and the median time to P/R was 25 months. As compared with CNN using MRI (accuracy 83%, precision 87%, and AUC 0.84) or MLP using clinical data (accuracy 73%, precision 73%, and AUC 0.73) alone, the multimodal CNN-MLP model using both clinical and MRI features showed the best performance for prediction of P/R in NFMAs, with accuracy 83%, precision 90%, and AUC 0.85.ConclusionsDL architecture incorporating clinical and MRI features performs well to predict P/R in NFMAs. Pending more studies to support the findings, the results of this study may provide valuable information for NFMAs treatment planning.https://www.frontiersin.org/articles/10.3389/fonc.2022.813806/fulldeep learningpituitarymacroadenomaprogressionrecurrenceMRI
spellingShingle Yan-Jen Chen
Yan-Jen Chen
Hsun-Ping Hsieh
Kuo-Chuan Hung
Kuo-Chuan Hung
Yun-Ju Shih
Sher-Wei Lim
Sher-Wei Lim
Yu-Ting Kuo
Yu-Ting Kuo
Jeon-Hor Chen
Jeon-Hor Chen
Ching-Chung Ko
Ching-Chung Ko
Ching-Chung Ko
Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features
Frontiers in Oncology
deep learning
pituitary
macroadenoma
progression
recurrence
MRI
title Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features
title_full Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features
title_fullStr Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features
title_full_unstemmed Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features
title_short Deep Learning for Prediction of Progression and Recurrence in Nonfunctioning Pituitary Macroadenomas: Combination of Clinical and MRI Features
title_sort deep learning for prediction of progression and recurrence in nonfunctioning pituitary macroadenomas combination of clinical and mri features
topic deep learning
pituitary
macroadenoma
progression
recurrence
MRI
url https://www.frontiersin.org/articles/10.3389/fonc.2022.813806/full
work_keys_str_mv AT yanjenchen deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT yanjenchen deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT hsunpinghsieh deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT kuochuanhung deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT kuochuanhung deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT yunjushih deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT sherweilim deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT sherweilim deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT yutingkuo deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT yutingkuo deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT jeonhorchen deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT jeonhorchen deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT chingchungko deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT chingchungko deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures
AT chingchungko deeplearningforpredictionofprogressionandrecurrenceinnonfunctioningpituitarymacroadenomascombinationofclinicalandmrifeatures